Skip to Content
  • MyChart

    Log in to our secure, personalized website to manage your care (formerly myMDAnderson).

  • Request an Appointment

    If you are ready to make an appointment, select a button on the right. If you have questions about UT MD Anderson’s appointment process, our information page may be the best place to start.

    Appointment Information
    New Patients Current Patients Referring Physicians
  • Every Breakthrough
    Begins With You

    Gifts to UT MD Anderson’s historic philanthropic campaign help accelerate discovery, transform lives and bring hope to more patients than ever before.

    Learn more about Only Possible Here
    Donate Today only-possible-here-logo
The University of Texas MD Anderson Cancer Center
  • Clinical Trials
  • Locations
  • Careers
  • Contact Us
  • Our Doctors
    • Español
    • عربى
    • 中文
    • Türkçe
Clear
close
      MyChart
      Donate Today
      • Clinical Trials
      • Locations
      • Careers
      • Contact Us
        • Español
        • عربى
        • 中文
        • Türkçe
      • Request an Appointment
      • New Patients
      • Current Patients
      • Referring Physicians
      • Patients & Family
          • Becoming Our Patient Home
          • Why UT MD Anderson
          • Planning for Care
          • Getting to UT MD Anderson
          • While You're Here
          • International Center
          • Services and Amenities
          • Insurance & Billing
          • Second Opinion Appointments
          • Diagnosis & Treatment Home
          • Cancer Types
          • A New Diagnosis
          • Treatment Options
          • Care Centers & Clinics
          • Emotional & Physical Effects
          • Patient Support
          • Clinical Trials
          • Supporting a Loved One Home
          • Caregiver Roles & Challenges
          • Children and Teens
          • Taking Care of Yourself
          • Helping a UT MD Anderson Patient
          • Dealing with Loss
          • Life After Cancer Home
          • Follow-up Care After Cancer Treatment
          • Long-Term Effects of Cancer
          • Social & Emotional Impacts of Cancer
          • Legal & Financial Impacts of Cancer
          • Survivorship Week
        • Request an Appointment Current Patients

          Find information and resources for current and returning patients.

          Clinical Trials

          Learn about clinical trials at UT MD Anderson and search our database for open studies.

      • Prevention & Screening
          • Manage Your Risk Home
          • Tobacco Control
          • Diet
          • Body Weight
          • Physical Activity
          • Skin Safety
          • HPV
          • Hepatitis
          • Alcohol
          • Family History Home
          • Genetic Testing
          • Hereditary Cancer Syndromes
          • Genetic Counseling and Testing FAQs
          • Cancer Screenings Home
          • Mammograms & Breast Cancer Screening
          • Cervical Cancer Screening
          • Colorectal Cancer Screening
          • Endometrial Cancer Screening
          • Liver Cancer Screening
          • Lung Cancer Screening
          • Mobile Mammography
          • Ovarian Cancer Screening
          • Prostate Cancer Screening
          • Skin Cancer Screening
          • Women's Cancer Screening
          • Men's Cancer Screening
        • Cancer Prevention Center 

          The Lyda Hill Cancer Prevention Center provides cancer risk assessment, screening and diagnostic services.

      • Donors & Volunteers
          • Donate Home
          • Raise Money
          • Honor Loved Ones
          • Create Your Legacy
          • Endowments
          • Caring Fund
          • Matching Gifts
          • Foundation and Corporation Relations
          • Volunteer Home
          • Why Volunteer
          • On-Site Volunteers
          • Volunteer Endowment
          • Patient Experience
          • Teen Volunteer Leadership Program
          • Children's Cancer Hospital Councils
          • Other Ways to Help Home
          • Give Blood
          • Shop UT MD Anderson
          • Children's Art Project
          • Donate Goods or Services
          • Attend Events
          • Cord Blood Bank
          • Corporate Alliances Home
          • Current Alliances
        • Join the Campaign to End Cancer 

          Help us celebrate and fuel the groundbreaking innovations and transformative advancements that define UT MD Anderson.

      • For Physicians
          • Refer a Patient Home
          • Health Care Provider Resource Center
          • Referring Provider Team
          • Insurance Information
          • International Referrals
          • myMDAnderson for Physicians
          • Second Opinion Pathology
          • Clinical Trials Home
          • Clinical Tools & Resources Home
          • Clinical Calculators
          • Clinical Practice Algorithms
        • myMDAnderson for Physicians 

          Our personalized portal helps you refer your patients and communicate with their UT MD Anderson care team.

      • Research
          • Departments, Labs and Institutes Home
          • Departments and Divisions
          • Labs
          • Research Centers and Programs
          • Institutes
          • Specialized Programs of Research Excellence (SPORE) Grants
          • Research Areas Home
          • Basic Science
          • Translational Research
          • Clinical Research
          • Prevention & Personalized Risk Assessment
          • Research Resources Home
          • Excellence in Science
          • Core Facilities and Services
          • Conferences & Seminars
          • Why Research at UT MD Anderson
          • STRIDE
          • NCI-Designated Cancer Center
          • Data Resources
        • Clinical Trials 

          As part of our mission to eliminate cancer, UT MD Anderson researchers conduct hundreds of clinical trials to test new treatments for both common and rare cancers.

      • Education & Training
          • Degree-Granting Schools Home
          • School of Health Professions
          • MD Anderson UTHealth Houston Graduate School
          • Research Training Home
          • Early Career Pathway Programs
          • Predoctoral Training
          • Postdoctoral Training
          • Mentored Faculty Programs
          • Career Development
          • Clinical Training Home
          • Graduate Medical Education
          • Clinical Education for Non-Physicians
          • Nursing Education & Training
          • Continuing Education & Review Courses
          • Simulation Center
          • Continuing Education & Professional Development Home
          • Continuing Professional Education/Conferences
          • Administrative Internships & Fellowships
          • Cancer Survivorship Professional Education
          • Leadership Institute
          • Patient Home Visits
          • Education Resources Home
          • Alumni Relations
          • Education Design Services
          • Awards & Recognitions
          • Academic Mentoring Council
          • Why UT MD Anderson & Houston
          • Outreach Programs Home
          • Project ECHO
          • Observer Programs
          • Comparative Effectiveness Training (CERTaIN)
          • Faculty Speakers Bureau
        • Apply to SHP

          Choose from 12 allied health programs at School of Health Professions.

          Research Trainees

          View open postdoctoral and other research trainee positions.

          GME Fellowships

          Learn about our graduate medical education residency and fellowship opportunities.

      Abel Trujillo-Ocampo Image

      Abel Trujillo-Ocampo, Ph.D.

      Department of Hematopoietic Biology & Malignancy, Division of Cancer Medicine

      Present Title & Affiliation

      Primary Appointment

      Instructor, Hematopoietic Biology and Malignancy, The University of Texas MD Anderson Cancer Center, Houston, TX

      Dual/Joint/Adjunct Appointment

      Instructor, Hematopoietic Biology and Malignancy, The University of Texas MD Anderson Cancer Center, Houston, TX

      Education & Training

      Degree-Granting Education

      2016Centro de Investigacion y de Estudios Evanzados del IPN,, CINVESTAV-IPN, MX, Immunology, Ph.D
      2011Centro de Investigacion y de Estudios Avanzados del IPN,, CINVESTAV-IPN, MX, Immunology, M.S
      2009Universidad Autonoma de Guerrero, Chilpancingo, MX, Chemistry, Biology Parasitology, BS

      Postgraduate Training

      2017-2023Research Fellowship, Department of Stem Cells Transplantation/ Hematopoietic Biology and Malignancy, The University of Texas MD Anderson Cancer Center, Houston, Texas

      Experience & Service

      Other Professional Positions

      Postdoctoral Fellow, Department of Stem Cell Transplantation, The University of Texas MD Anderson Cancer Center, Houston, TX, 2017 - 2023

      Teacher, Justo Sierra University Cultural Center, Ciudad de México, 2016 - 2016

      Honors & Awards

      2022 - 2024New Investigator Award, American Society for Transplantation and Cellular Therapy (ASTCT)
      2021 - 2022Careers in Immunology Fellowships, American Association of Immunologists (AAI)
      2011 - 2015Ph.D. Degree Scholarship, Consejo Nacional de Humanidades, Ciencias y Tecnologias (CONACyT)
      2009 - 2011Master's Degree Scholarship, Consejo Nacional de Humanidades, Ciencias y Tecnologias (CONACyT)

      Selected Presentations & Talks

      National Presentations

      1. 2024. Cord-Derived Invariant Natural Killer T Cells As Novel Cell Therapy to Improve the Outcome of Hematopoietic Stem Cell Transplantation. Poster, US.
      2. 2018. Ex vivo expansion of human iNKT cells for adoptive therapy-GVHD. Conference. Immunology department. Galveston, TX, US.
      3. 2017. Ex vivo expansion of iNKT cells for adoptive cell therapy. Poster. CD1-MR1 meeting. Napa, California, US.

      International Presentations

      1. 2020. Investigation cord derived human invariant natural killer T cells as potential immune-regulators to prevent Graft Versus Host Disease. Invited. 30th DIPM Anniversary, session 6. Enfermedades cronico-degenerativas. Mexico City (on line), MX.
      2. 2018. Ex vivo expansion of iNKT cells as novel adoptive therapy to modulate GVHD. Invited. Juarez Hospital. Mexico city, MX.
      3. 2013. Advances and perspectives of flow cytometry. Invited. National Laboratory of Experimental Services (LaNSE). Mexico City, MX.

      Formal Peers

      1. 2011. Cell cycle and apoptosis. Invited. Mexico City, MX.
      Read More
      Less

      Selected Publications

      Peer-Reviewed Articles

      1. Trujillo-Ocampo A. Cord-Derived Inkt Cells are Enriched with Human NKT10s and Mediate Immune-Regulation via Neuropilin-1. e-Pub 2025.
      2. Maison Grefe, Trujillo-Ocampo A. Cord blood-derived iNK T cells as a platform for allogeneic CAR T cell therapy. Front Immunol, 2025. e-Pub 2025. PMID: 40519924.
      3. Raychaudhuri D, Singh P, Hennessey M, Chakraborty B, Tannir AJ, Trujillo-Ocampo A, Im JS, Goswami S. Histone Lactylation Drives CD8 T Cell Metabolism and Function. bioRxiv, 2024. e-Pub 2024. PMID: 38854142.
      4. Lee SE, Wang F, Grefe M, Trujillo-Ocampo A, Ruiz-Vasquez W, Takahashi K, Abbas HA, Borges P, Antunes DA, Al-Atrash G, Daver N, Molldrem JJ, Futreal A, Garcia-Manero G, Im JS. Immunologic Predictors for Clinical Responses during Immune Checkpoint Blockade in Patients with Myelodysplastic Syndromes. Clin Cancer Res 29(10):1938-1951, 2023. e-Pub 2023. PMID: 36988276.
      5. Pareek S, Flegle AS, Boagni D, Kim JY, Yoo D, Trujillo-Ocampo A, Lee SE, Zhang M, Jon S, Im JS. Post Transplantation Bilirubin Nanoparticles Ameliorate Murine Graft Versus Host Disease via a Reduction of Systemic and Local Inflammation. Front Immunol 13:893659, 2022. e-Pub 2022. PMID: 35720391.
      6. Lee SE, Wang F, Trujillo-Ocampo A, Ruiz-Vasquez W, Cho HW, Takahashi K, Molldrem JJ, Futreal A, Garcia-Manero G, Im JS. Fidelity of peripheral blood for monitoring genomics and tumor immune-microenvironment in myelodysplastic syndromes. EJHaem 1(2):552-557, 2020. e-Pub 2020. PMID: 35844984.
      7. Trujillo-Ocampo A, Cho HW, Clowers M, Pareek S, Ruiz-Vazquez W, Lee SE, Im JS. IL-7 During Antigenic Stimulation Using Allogeneic Dendritic Cells Promotes Expansion of CD45RA-CD62L+CD4+ Invariant NKT Cells With Th-2 Biased Cytokine Production Profile. Front Immunol 11:567406, 2020. e-Pub 2020. PMID: 33329531.
      8. Trujillo-Ocampo A, Cho HW, Herrmann AC, Ruiz-Vazquez W, Thornton AB, He H, Li D, Qazilbash MA, Ma Q, Porcelli SA, Shpall EJ, Molldrem J, Im JS. Rapid ex vivo expansion of highly enriched human invariant natural killer T cells via single antigenic stimulation for cell therapy to prevent graft-versus-host disease. Cytotherapy 20(8):1089-1101, 2018. e-Pub 2018. PMID: 30076070.
      9. Trujillo-Ocampo A, Cázares-Raga FE, Del Angel RM, Medina-Ramírez F, Santos-Argumedo L, Rodríguez MH, Hernández-Hernández FC. Participation of 14-3-3ε and 14-3-3ζ proteins in the phagocytosis, component of cellular immune response, in Aedes mosquito cell lines. Parasit Vectors 10(1):362, 2017. e-Pub 2017. PMID: 28764795.
      10. González-López L, Carballar-Lejarazú R, Arrevillaga Boni G, Cortés-Martínez L, Cázares-Raga FE, Trujillo-Ocampo A, Rodríguez MH, James AA, Hernández-Hernández FC. Lys48 ubiquitination during the intraerythrocytic cycle of the rodent malaria parasite, Plasmodium chabaudi. PLoS One 12(6):e0176533, 2017. e-Pub 2017. PMID: 28604779.
      11. Trujillo-Ocampo A, Cázares-Raga FE, Celestino-Montes A, Cortés-Martínez L, Rodríguez MH, Hernández-Hernández FC. IDENTIFICATION AND EXPRESSION ANALYSIS OF TWO 14-3-3 PROTEINS IN THE MOSQUITO Aedes aegypti, AN IMPORTANT ARBOVIRUSES VECTOR. Arch Insect Biochem Physiol 93(3):143-159, 2016. e-Pub 2016. PMID: 27592842.

      Other Articles

      1. Trujillo-Ocampo, A, Cho, HW, Pareek, S, RUIZ-VAZQUEZ, W, Clowers, MJ, Lee, SE, Im, JS Corrigendum. Frontiers in immunology 12, 2021. PMID: 33959134.

      Abstracts

      1. Trujillo-Ocampo A. Cord-Derived Invariant Natural Killer T Cells As Novel Cell Therapy to Improve the Outcome of Hematopoietic Stem Cell Transplantation Blood (2024) 144 (Supplement 1): 4818. e-Pub 2024.
      2. al TE. LRP1-deficient T cells protect against acute Graft Versus Host Disease in MHC-Mismatched Mice. American society of hematologist, 2022. e-Pub 2022.
      3. al TE. Cord-derived human natural killer T cells are enriched with NKT10 subsets and ameliorate xeno Graft Versus Host Disease. Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR, 2021. e-Pub 2021.
      4. al TE. Ex Vivo expansion of iNKT cell for adoptive cell therapy. CD1-MR1 2017 meeting, Napa, California, USA, 2017. e-Pub 2017.
      5. al TE. Expression analysis and tissue distribution of 14-3-3 isoforms in Aedes aegypti. 13th INTERNATIONAL CONGRESS OF PARASITOLOGY, Mexico City, Mexico, 2014. e-Pub 2014.
      6. al TE. Identification and analysis of expression of 14-3-3 isoforms in Aedes aegypti. Seventh International Symposium on Molecular Insect Science, Amsterdam, The Netherland, 2014. e-Pub 2014.
      7. al TE. Production and characterization of polyclonal antibodies against CD38. The American Association of Immunologist AAI Annual meeting, San Francisco, California, USA, 2011. e-Pub 2011.
      8. Greife M, Trujillo-Ocampo A, Boagni D, Clinton J, He H, Clise-Dwyer K, Cho H, Shpall EJ, Molldrem JJ, Im SJ. Cord Derived 8F4CAR-iNKT Cells to Prevent Acute Myeloid Leukemia Relapse and Graft Vs. Host Disease after Allogeneic Stem Cell Transplantation. American Society of Hematology.
      9. Sizova, Li Dan, Ma Qing, St John Lisa, Clise-Dwyer K, Trujillo-Ocampo A, Molldrem JJ. LRP1-Deficient T Cells Protect Against Acute Graft Versus Host Disease in MHC-Mismatched Mice. American Society of Hematology.
      10. Trujillo-Ocampo A. Cord-Derived Invariant Natural Killer T Cells As Novel Cell Therapy to Improve the Outcome of Hematopoietic Stem Cell Transplantation. ASH.
      Read More
      Less

      Patient Reviews


      CV information above last modified July 22, 2026

      Request an Appointment

      Whether you are ready to make an appointment now or have questions for our expert team, we are standing by to help.
      Learn more

      Related Links

      • Care Centers and Clinics

      • Departments and Divisions

      • Labs

      Clinical Trials

      Our patients have access to clinical trials offering promising new treatments that cannot be found anywhere else.
      Learn more

      Help #EndCancer

      Give Now

      Your gift will help make a tremendous difference.
      Donate

      Donate Blood

      Our patients depend on blood and platelet donations.

      Make an appointment

      Shop UT MD Anderson

      Show your support for our mission through branded merchandise.

      View products
      Subscribe to our Cancerwise newsletter
      UT MD Anderson logoUT MD Anderson logo
      • Explore
      • Patients & Family
      • Prevention & Screening
      • Donors & Volunteers
      • For Physicians
      • Research
      • Education & Training
      • Clinical Trials
      • Languages
      • About
      • About UT MD Anderson
      • Careers
      • Blog
      • Newsroom
      • Editorial Standards
      • For Employees
      • Merchandise
      • Title IX Reporting (Sexual Misconduct)
      • Price Transparency
      • Finding Your Way
      • Our Doctors
      • Locations
      • Directions
      • Sitemap
      • DIGITAL ACCESSIBILITY
      • Accessibility Policy MD Anderson works with Level Access to ensure our website is accessible and functional for all users. Free assistive technology is provided for people with physical disabilities. To learn more or to download the assistive technology tool, visit https://www.levelaccess.com/MDAnderson
      • GET IN TOUCH
      • Call
        1-877-632-6789
      • Ask a question
      • Stay Connected
      • Cancerwise Podcast
      • More
      • Website Privacy Policy
      • Legal Statement & Policies
      • Reports to the State
      • Emergency Alert Information
      • State of Texas Links
      • Our Cancer Network
      • Vendors & Suppliers
      UT MD Anderson logo
      The mission of The University of Texas MD Anderson Cancer Center is to eliminate cancer in Texas, the nation, and the world through outstanding programs that integrate patient care, research and prevention, and through education for undergraduate and graduate students, trainees, professionals, employees and the public.

      © 2026 The University of Texas MD Anderson Cancer Center. All rights reserved.

      Top